The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to ...

A MAN claims his member was infected with drug resistant E.coli – after using a bidet. Initially thinking he had a cold or ...

A mild UTI may last days or under a week. These are sometimes called uncomplicated UTIs. Learn how long a complicated UTI ...

New research has found that an enlarged prostate gland is causing serious problems for more than 2.8 million Australian men ...

Veterinarians should become familiar with new definitions and recommendations for managing urinary tract infections in dogs ...

Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum ...

Sir Chris Hoy, six-time Olympic cycling champion, has revealed he has advanced prostate cancer. The 48-year-old said the ...

Urinary tract infections are common, especially, though not exclusively, in women, and the risk generally increases with age.

Oct. 28, 2024 –The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

Some patients with prostate enlargement and cancer recount how their symptoms were mistaken for sexually transmitted ...

Blood samples of patients infected with a parasitic worm that causes schistosomiasis contain hidden information that marks ...